Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 351204, 8 pages
http://dx.doi.org/10.1155/2014/351204
Research Article

Association of Levels of Antibodies from Patients with Inflammatory Bowel Disease with Extracellular Proteins of Food and Probiotic Bacteria

1Instituto de Productos Lácteos de Asturias, Consejo Superior de Investigaciones Científicas (IPLA-CSIC), Paseo Río Linares s/n, Villaviciosa, 33300 Asturias, Spain
2Department of Functional Biology, Immunology Area, University of Oviedo, C/Julián Clavería s/n, Oviedo, 33006 Asturias, Spain
3UMR 5248 CBMN CNRS-Université Bordeaux 1-ENITAB, Laboratoire de Microbiologie et Biochimie Appliquée, 1 Cours du Général de Gaulle, 33175 Gradignan Cedex, France
4Nutrition and Bromatology Group, Department of Analytical and Food Chemistry, Food Science and Technology Faculty, University of Vigo, Ourense Campus, 32004 Ourense, Spain

Received 27 February 2014; Revised 18 May 2014; Accepted 19 May 2014; Published 4 June 2014

Academic Editor: Julio Villena

Copyright © 2014 Arancha Hevia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Manichanh, N. Borruel, F. Casellas, and F. Guarner, “The gut microbiota in IBD,” Nature Reviews Gastroenterology and Hepatology, vol. 9, no. 10, pp. 599–608, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. S. K. Mazmanian, J. L. Round, and D. L. Kasper, “A microbial symbiosis factor prevents intestinal inflammatory disease,” Nature, vol. 453, no. 7195, pp. 620–625, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Manichanh, L. Rigottier-Gois, E. Bonnaud et al., “Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach,” Gut, vol. 55, no. 2, pp. 205–211, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Lepage, R. Hösler, M. E. Spehlmann et al., “Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis,” Gastroenterology, vol. 141, no. 1, pp. 227–236, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Duboc, S. Rajca, D. Rainteau et al., “Connecting dysbiosis, bile-acid dysmetabolism and Gut inflammation in inflammatory bowel diseases,” Gut, vol. 62, no. 4, pp. 531–539, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. X. C. Morgan, T. L. Tickle, H. Sokol et al., “Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment,” Genome Biology, vol. 13, article R79, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Qin, R. Li, J. Raes et al., “A human gut microbial gene catalogue established by metagenomic sequencing,” Nature, vol. 464, pp. 59–65, 2010. View at Publisher · View at Google Scholar
  8. N. Borruel, M. Carol, F. Casellas et al., “Increased mucosal tumour necrosis factor α production in Crohn's disease can be downregulated ex vivo by probiotic bacteria,” Gut, vol. 51, no. 5, pp. 659–664, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Carol, M. Llopis, M. Antolin et al., “Viable bacteria versus DNA extracts as anti-inflammatory agents in Crohn's disease,” Gastroenterology, vol. 130, p. A128, 2006. View at Google Scholar
  10. M. Llopis, M. Antolin, M. Carol et al., “Lactobacillus casei downregulates commensals' inflammatory signals in Crohn's disease mucosa,” Inflammatory Bowel Diseases, vol. 15, no. 2, pp. 275–283, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Salque, P. I. Bogucki, J. Pyzel et al., “Earliest evidence for cheese making in the sixth millennium bc in northern Europe,” Nature, vol. 493, no. 7433, pp. 522–525, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Sánchez, L. Ruiz, M. Gueimonde, P. Ruas-Madiedo, and A. Margolles, “Toward improving technological and functional properties of probiotics in foods,” Trends in Food Science and Technology, vol. 26, no. 1, pp. 56–63, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Schoepfer, T. Schaffer, S. Mueller et al., “Phenotypic associations of Crohn's disease with antibodies to flagellins A4-Fla2, Fla-X, ASCA, pANCA and CARD15 mutations in a Swiss cohort,” Gastroenterology, vol. 134, p. A198, 2008. View at Google Scholar
  14. A. M. Petersen, C. Schou, J. H. Engberg et al., “E. coli outer membrane protein C antibodies in active and inactive Inflammatory Bowel Disease,” Gastroenterology, vol. 140, p. S330, 2011. View at Google Scholar
  15. M. E. Spehlmann and A. Kromminga, “Antibodies to self and bacterial antigens in patients with Crohn's disease and ulcerative colitis: a co-twin case-control study,” Gastroenterology, vol. 130, p. A362, 2006. View at Google Scholar
  16. A. Schoepfer, T. Schaffer, B. Seibold-Schmid, S. Mueller, and F. Seibold, “Elevated antibodies against flagellin support the concept of low grade mucosal inflammation in irritable bowel syndrome,” Gastroenterology, vol. 132, p. A705, 2007. View at Google Scholar
  17. B. Sánchez, S. Chaignepain, J.-M. Schmitter, and M. C. Urdaci, “A method for the identification of proteins secreted by lactic acid bacteria grown in complex media,” FEMS Microbiology Letters, vol. 295, no. 2, pp. 226–229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. U. K. Laemmli, “Cleavage of structural proteins during the assembly of the head of bacteriophage T4,” Nature, vol. 227, no. 5259, pp. 680–685, 1970. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Halfvarson, A. Standaert-Vitse, G. Järnerot et al., “Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease,” Gut, vol. 54, no. 9, pp. 1237–1243, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. P. A. Bron, P. Van Baarlen, and M. Kleerebezem, “Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa,” Nature Reviews Microbiology, vol. 10, no. 1, pp. 66–90, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Lebeer, J. Vanderleyden, and S. C. J. De Keersmaecker, “Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens,” Nature Reviews Microbiology, vol. 8, no. 3, pp. 171–184, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Sánchez, M. C. Urdaci, and A. Margolles, “Extracellular proteins secreted by probiotic bacteria as mediators of effects that promote mucosa-bacteria interactions,” Microbiology, vol. 156, no. 11, pp. 3232–3242, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Bernardo, B. Sánchez, H. O. Al-Hassi et al., “Microbiota/host crosstalk biomarkers: regulatory response of human intestinal dendritic cells exposed to Lactobacillus extracellular encrypted peptide,” PLoS ONE, vol. 7, no. 5, Article ID e36262, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Khounlotham, W. Kim, E. Peatman et al., “Compromised intestinal epithelial barrier induces adaptive immune compensation that protects from colitis,” Immunity, vol. 37, no. 3, pp. 563–573, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. R. J. Adams, S. P. Heazlewood, K. S. Gilshenan, M. O'Brien, M. A. McGuckin, and T. H. J. Florin, “IgG antibodies against common gut bacteria are more diagnostic for Crohn's disease than IgG against mannan or flagellin,” The American Journal of Gastroenterology, vol. 103, no. 2, pp. 386–396, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Furrie, S. Macfarlane, J. H. Cummings, and G. T. Macfarlane, “Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response,” Gut, vol. 53, no. 1, pp. 91–98, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. M. G. Gareau, P. M. Sherman, and W. A. Walker, “Probiotics and the gut microbiota in intestinal health and disease,” Nature Reviews. Gastroenterology & Hepatology, vol. 7, no. 9, pp. 503–514, 2010. View at Google Scholar · View at Scopus
  28. N. L. Zitomersky, M. J. Coyne, and L. E. Comstock, “Longitudinal analysis of the prevalence, maintenance, and IgA response to species of the order Bacteroidales in the human gut,” Infection and Immunity, vol. 79, no. 5, pp. 2012–2020, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. I. J. J. Claes, G. Schoofs, K. Regulski et al., “Genetic and biochemical characterization of the cell wall hydrolase activity of the major secreted protein of Lactobacillus rhamnosus GG,” PLoS ONE, vol. 7, no. 2, Article ID e31588, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Bäuerl, G. Pérez-Martínez, F. Yan, D. B. Polk, and V. Monedero, “Functional analysis of the p40 and p75 proteins from lactobacillus casei BL23,” Journal of Molecular Microbiology and Biotechnology, vol. 19, no. 4, pp. 231–241, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Sánchez, J.-M. Schmitter, and M. C. Urdaci, “Identification of novel proteins secreted by Lactobacillus rhamnosus GG grown in de Mann-Rogosa-Sharpe broth,” Letters in Applied Microbiology, vol. 48, no. 5, pp. 618–622, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Seth, F. Yan, D. B. Polk, and R. K. Rao, “Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 294, no. 4, pp. G1060–G1069, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Yan, H. W. Cao, M. K. Washington, and D. B. Polk, “Prevention of DSS-induced colitis in mice by a probiotic-derived soluble protein,” Gastroenterology, vol. 134, p. A36, 2008. View at Google Scholar
  34. H. Nakase, A. Nishio, H. Tamaki et al., “Specific antibodies against recombinant protein of insertion element 900 of Mycobacterium avium subspecies paratuberculosis in Japanese patients with Crohn's disease,” Inflammatory Bowel Diseases, vol. 12, no. 1, pp. 62–69, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. H. H. Ko, H. Bach, E. A. Raizman, R. A. Enns, and B. Bressler, “Presence of serum antibodies against secreted proteins from Mycobacterium avium spp paratuberculosis in patients with Crohn's Disease,” Gastroenterology, vol. 136, p. A353, 2009. View at Google Scholar
  36. G. P. Manukyan, K. A. Ghazaryan, Z. A. Ktsoyan et al., “Elevated systemic antibodies towards commensal gut microbiota in autoinflammatory condition,” PLoS ONE, vol. 3, no. 9, Article ID e3172, 2008. View at Publisher · View at Google Scholar · View at Scopus